TransPerfect Life Sciences Announces eCOA LingCert Program

New Accreditation Certifies eCOA Technology Platforms

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced the rollout of its certification solution for accrediting electronic clinical outcome assessment (eCOA) technology platforms based on their ability to host eCOA localized materials according to industry standards, best practices, and sponsor needs.

The solution, called eCOA LingCert, has three certification levels: Silver, Gold, and Platinum. Each tier is awarded based on a platform’s ability to meet functional standards for success across four categories:

• Content management
• Internationalization
• Post-localization testing
• Content reusability

Several recent accreditations in the space, including Clario’s “eCOA Tablet,” have helped spotlight platform improvements, delivering 360-degree advancements.

Terry Burke, EVP of eCOA at Clario, said, “TransPerfect's new certification helps to differentiate COA offerings on the market while making it easier for us to demonstrate that we are delivering a best-in-class experience for our clients and their patients.”

eCOA LingCert is intended to mitigate issues with transferring electronically migrated COAs to clinical trial participants, as any setback ultimately results in higher costs and delayed timelines. With this certification, eCOA platforms are also well-positioned to reduce translation costs and enhance overall eCOA quality by aligning with and meeting sponsor expectations.

The recently accredited Clinical ink platform is paving the way for additional process excellence standards across the company’s entire technology portfolio.

Megan Petrylak, EVP of Customer Delivery at Clinical ink, commented, “Partnering for a consistent framework allows us to reliably measure against industry standards and has helped us pinpoint features to drive conversations with sponsors regarding what they care about the most.”

TransPerfect President and CEO Phil Shawe stated, “We're excited to now offer the eCOA LingCert accreditation program. This certification gives our life sciences clients and partners a standardized approach to hosting localized eCOA materials.”

Learn more about TransPerfect’s eCOA solutions at COASolutions@transperfect.com.

About Clario

Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario’s eCOA Digital Solutions have been powering hybrid and decentralized clinical trials (DCT) for over 20 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving the patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory approvals for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.

About Clinical ink

Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.

About TransPerfect Life Sciences

TransPerfect Life Sciences specializes in supporting global development and commercialization of drugs, treatments, and devices designed to improve and save lives. Our comprehensive solutions include eTMF and eClinical technologies, paper TMF migration, pharmacovigilance and safety solutions, translation and language services, and call center support. With offices in over 100 cities worldwide, TransPerfect is the ideal partner to ensure that your global launch makes a global impact. For more information, please visit our website at https://lifesciences.transperfect.com/.

About TransPerfect

TransPerfect is the world’s largest provider of language and technology solutions for global business. From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 200+ languages to clients worldwide. More than 6,000 global organizations employ TransPerfect’s GlobalLink® technology to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. Visit https://www.transperfect.com for more information on TransPerfect.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005185/en/